表紙
市場調查報告書

放射線治療的品質保證 (QA) 模體的全球市場分析、預測 (技術、治療方法、地區、資料) :2019-2024年

Global Radiation Therapy Quality Assurance (QA) Phantoms Market: Focus on Technology, Therapies, Regions, Data - Analysis and Forecast, 2019-2024

出版商 BIS Research Inc. 商品編碼 914461
出版日期 內容資訊 英文 175 Pages
商品交期: 最快1-2個工作天內
價格
放射線治療的品質保證 (QA) 模體的全球市場分析、預測 (技術、治療方法、地區、資料) :2019-2024年 Global Radiation Therapy Quality Assurance (QA) Phantoms Market: Focus on Technology, Therapies, Regions, Data - Analysis and Forecast, 2019-2024
出版日期: 2019年10月15日內容資訊: 英文 175 Pages
簡介

全球放射線治療的品質保證 (QA) 模體市場,預計至2024年達到3,026萬美元。

本報告提供全球放射線治療的品質保證 (QA) 模體市場調查,產業結構,主要企業的主要的發展策略,未來市場發展,主要市場的影響要素,主要企業,主要的技術進步與預期影響,法規形勢,市場規模,各地區的成長預測等資料彙整。

摘要整理

第1章 市場定義

第2章 調查範圍

第3章 調查手法

第4章 產業的考察

  • 放射線治療的技術趨勢
  • 成像技術的工作流程
  • 法律規範
  • 專利分析
  • 價值鏈分析

第5章 競爭情形

  • 市場佔有率分析
  • 價值鏈分析

第6章 市場動態

  • 市場成長的促進因素
  • 市場課題/阻礙因素

第7章 全球放射線治療的品質保證 (QA) 模體市場:各技術

  • 預測的前提條件、限制事項
  • 概要
  • 線性加速器
  • 鈷-60
  • 高輻射劑量放射線
  • 低輻射劑量放射線

第8章 全球放射線治療的品質保證 (QA) 模體市場:各治療法

  • 預測的前提條件、限制事項
  • 概要
  • 體外放射治療
  • 體內照射療法或近距離放射治療

第9章 全球放射線治療的品質保證 (QA) 模體市場:各地區

  • 預測的前提條件、限制事項
  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (RoW)

第10章 企業簡介

  • 概要
  • Computerized Imaging Reference Systems, Inc.
  • Fluke Biomedical
  • IBA Dosimetry
  • Modus Medical Devices Inc.
  • PTW Freiburg GmbH
  • Standard Imaging Inc.
  • Sun Nuclear Corporation
  • The Phantom Laboratory, Inc.
目錄
Product Code: BH159A

Global Radiation Therapy Quality Assurance Phantoms Market to Reach $30.26 Million by 2024, Reports BIS Research.

Key Questions Answered in this Report:

  • What is the industry structure of the global radiation therapy quality assurance phantoms market?
  • How many patents are currently active in the global radiation therapy quality assurance phantoms market?
  • What are the key development strategies which are implemented by the key players to stand put in the market?
  • How did the radiation therapy quality assurance phantoms market evolve and what is its scope in the future?
  • What are the major market drivers, challenges, and opportunities in the global radiation therapy quality assurance phantoms market?
  • What are the leading companies dominating the global radiation therapy quality assurance phantoms market?
  • What are the key technological advancements in radiation therapy which are expected to impact the growth of phantoms?
  • What are the regulations pertaining to the global radiation therapy quality assurance phantoms market?
  • What was the market value of the leading segments (technologies, therapies, and region) of the global radiation therapy quality assurance phantoms market in 2018?
  • How is each segment of the global radiation therapy quality assurance phantoms market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2024?
  • How is the industry expected to evolve during the forecast period 2019-2024?
  • Which region carries the potential for the significant expansion of key companies for radiation therapy quality assurance phantoms market?

Global Radiation Therapy Quality Assurance Phantoms Market Forecast, 2019-2024

Radiation Therapy Quality Assurance Phantoms Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 4.59% during the forecast period 2019-2024. The radiation therapy quality assurance phantoms market generated $23.13 million revenue in 2018, in terms of value.

The radiation therapy quality assurance phantoms growth has been primarily attributed to the major drivers in this market such as enhanced patient and machine QA in radiation oncology, increasing demand for tissue equivalent phantoms, rise in the burden of cancer, and others. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product launches, and increasing partnerships and collaborations with the gamma knife manufacturers and other players in the market ecosystem. However, there are significant challenges which are restraining the market growth. These challenges include high cost of phantoms in the emerging economies, lack of product awareness in the emerging economies, and fierce market competition.

Expert Quote

"The radiation therapy market is looking for solutions which can reduce machine downtime, therapy time while enhancing patient experience and outcome. In such scenario, patient specific phantoms and phantom-less QA processes are expected to be focus area of the market."

Scope of the Market Intelligence on Radiation Therapy Quality Assurance Phantoms Market

The radiation therapy quality assurance phantoms market research provides a holistic view of global market in terms of various factors influencing it, including product launches and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products used in quality assurance procedures. In addition, the study also includes exhaustive information on impact of radiation therapy quality assurance phantoms on different technologies and therapies, perception on the product launches, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segments, and company, as well as other vital information with respect to global radiation therapy quality assurance phantoms market.

Market Segmentation

The radiation therapy quality assurance phantoms market segmentation (based on technology) is further segmented into linear accelerators, Cobalt-60, low-dose radiation, and high-dose radiation.

The radiation therapy quality assurance phantoms market segmentation (based on therapy) is further segmented into photon beam radiation therapy, stereotactic radiation therapy, advanced 3-D conformal radiation therapy, image guided radiation therapy, volumetric modulated arc therapy, intraoperative radiotherapy, proton beam therapy, neutron beam therapy, and brachytherapy.

Key Companies in the Global Radiation Therapy Quality Assurance Phantoms Market:

The key manufacturers who have been contributing significantly to the radiation therapy quality assurance phantoms market include Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., Sun Nuclear Corporation, and The Phantom Laboratory Inc., among others.

Table of Contents

Executive Summary

1. Market Definition

  • 1.1. Radiation Therapy
  • 1.2. Phantoms
  • 1.3. Phantoms in Quality Assurance

2. Scope of the Report

3. Research Methodology

  • 3.1. Research Methodology
    • 3.1.1. Data Triangulation
    • 3.1.2. Primary Data Sources
    • 3.1.3. Secondary Data Sources
    • 3.1.4. Bottom-up Approach
    • 3.1.5. Assumptions and Limitations

4. Industry Insights

  • 4.1. Technological Trends in Radiation Therapy
  • 4.2. Complete Workflow of Imaging Techniques
    • 4.2.1. QA Associated with IMRT
    • 4.2.2. QA Associated with Stereotactic Radiosurgery
  • 4.3. Regulatory Framework
    • 4.3.1. Regulatory Framework in the America
      • 4.3.1.1. Food and Drug Administration (FDA)
      • 4.3.1.2. United States Department of Health and Human Services (HHS)
      • 4.3.1.3. The American Society for Radiation Oncology (ASTRO)
      • 4.3.1.4. American Medical Association (AMA)
    • 4.3.2. Regulatory Framework in Europe
      • 4.3.2.1. European Commission (EC)
    • 4.3.3. Regulatory Framework in Asia-Pacific
  • 4.4. Patent Analysis
  • 4.5. Value Chain Analysis

5. Competitive Landscape

  • 5.1. Market Share Analysis
  • 5.2. Key Developments and Strategies
    • 5.2.1. Collaborations and Partnerships
    • 5.2.2. Product Launches
    • 5.2.3. Mergers and Acquisitions
    • 5.2.4. Business Expansion

6. Market Dynamics

  • 6.1. Market Drivers
    • 6.1.1. Enhanced Patient and Machine Quality Assurance in Radiation Therapy
    • 6.1.2. Use of Tissue Equivalent Phantoms
    • 6.1.3. Rising Burden of Cancer
  • 6.2. Market Challenges/Restraints
    • 6.2.1. Cost of Phantoms in Emerging Markets
    • 6.2.2. Increased Market Competition
    • 6.2.3. Skill Set Gap

7. Global Radiation Therapy Quality Assurance (QA) Phantoms Market (by Technology)

  • 7.1. Assumptions and Limitations
  • 7.2. Overview
  • 7.3. Linear Accelerators
  • 7.4. Cobalt-60
  • 7.5. High-Dose Radiation
  • 7.6. Low-Dose Radiation

8. Global Radiation Therapy Quality Assurance (QA) Phantoms Market (by Therapy)

  • 8.1. Assumptions and Limitations
  • 8.2. Overview
  • 8.3. External Radiation Therapy
    • 8.3.1. Photon Beam Radiation Therapy
    • 8.3.2. Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT)
    • 8.3.3. Volumetric Modulated Arc Therapy (VMAT)
    • 8.3.4. Image Guided Radiation Therapy (IGRT)
    • 8.3.5. Stereotactic Radiation Therapy
    • 8.3.6. Intraoperative Radiotherapy (IORT)
    • 8.3.7. Proton Beam Therapy
    • 8.3.8. Neutron Beam Therapy
  • 8.4 Internal Radiation Therapy or Brachytherapy

9. Global Radiation Therapy Quality Assurance Phantoms Market (by Region)

  • 9.1. Assumptions and Limitations
  • 9.2. Overview
    • 9.2.1. Analysis of Growth Potential of Different Countries
  • 9.3. North America
    • 9.3.1. U.S.
    • 9.3.2. Canada
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. Russia
    • 9.4.4. Italy
    • 9.4.5. U.K.
    • 9.4.6. Spain
    • 9.4.7. Rest-of-Europe
  • 9.5. Asia-Pacific
    • 9.5.1. China
    • 9.5.2. Japan
    • 9.5.3. India
    • 9.5.4. Australia
    • 9.5.5. South Korea
    • 9.5.6. Rest-of-Asia-Pacific
  • 9.6. Rest-of-the-World
    • 9.6.1. Latin America
      • 9.6.1.1. Brazil
      • 9.6.1.2. Mexico
      • 9.6.1.3. Rest-of-Latin-America
    • 9.6.2. Middle East and Africa
      • 9.6.2.1. Saudi Arabia
      • 9.6.2.2. Egypt
      • 9.6.2.3. South Africa

10. Company Profiles

  • 10.1. Overview
  • 10.2. Computerized Imaging Reference Systems, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Role of Computerized Imaging Reference Systems, Inc. in the Global Radiation Therapy QA Phantoms Market
      • 10.2.2.1. Product Mapping
      • 10.2.2.2. Recent Developments
      • 10.2.2.3. Mergers and Acquisitions
    • 10.2.3. SWOT Analysis
  • 10.3. Fluke Biomedical
    • 10.3.1. Company Overview
    • 10.3.2. Role of Fluke Biomedical in the Global Radiation Therapy QA Phantoms Market
      • 10.3.2.1. Product Mapping
      • 10.3.2.2. Recent Developments
      • 10.3.2.3. Mergers and Acquisitions
    • 10.3.3. SWOT Analysis
  • 10.4. IBA Dosimetry
    • 10.4.1. Company Overview
    • 10.4.2. Role of IBA Dosimetry in the Global Radiation Therapy QA Phantoms Market
      • 10.4.2.1. Product Mapping
      • 10.4.2.2. Recent Developments
    • 10.4.3. Financials
    • 10.4.4. SWOT Analysis
  • 10.5. Modus Medical Devices Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Role of Modus Medical Devices Inc. in the Global Radiation Therapy QA Phantoms Market
      • 10.5.2.1. Product Mapping
    • 10.5.3. SWOT Analysis
  • 10.6. PTW Freiburg GmbH
    • 10.6.1. Company Overview
    • 10.6.2. Role of PTW Freiburg GmbH in the Global Radiation Therapy QA Phantoms Market
      • 10.6.2.1. Product Mapping
    • 10.6.3. SWOT Analysis
  • 10.7. Standard Imaging Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Role of Standard Imaging Inc. in the Global Radiation Therapy QA Phantoms Market
      • 10.7.2.1. Product Mapping
      • 10.7.2.2. Recent Developments
    • 10.7.3. SWOT Analysis
  • 10.8. Sun Nuclear Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Role of Sun Nuclear Corporation in the Global Radiation Therapy QA Phantoms Market
      • 10.8.2.1. Product Mapping
      • 10.8.2.2. Recent Developments
    • 10.8.3. SWOT Analysis
  • 10.9. The Phantom Laboratory, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Role of The Phantom Laboratory, Inc. in the Global Radiation Therapy QA Phantoms Market
      • 10.9.2.1. Product Mapping
    • 10.9.3. SWOT Analysis

List of Tables

  • Table 1: Regional Data for Cancer Patients, Global, 2018
  • Table 4.1: Regulatory Authorities/Associations/Consortiums for Medical Devices in Americas
  • Table 4.2: Regulatory Authorities/Associations/Consortiums for Medical Devices in Europe
  • Table 4.3: Regulatory Authorities/Associations/Consortiums for Medical Devices in Asia-Pacific
  • Table 4.4: Patent Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market (by Assignee)
  • Table 5.1: Competitors' Snapshot for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
  • Table 6.1: Planning Process in Radiation Therapy QA
  • Table 8.1: Global Radiation Therapy QA Phantoms Market (by Volume: by Therapy), 2019-2024
  • Table 10.1: Product Mapping: Computerized Imaging Reference Systems, Inc.
  • Table 10.2: Product Mapping: Fluke Biomedical
  • Table 10.3: Product Mapping: IBA Dosimetry
  • Table 10.4: Product Mapping: Modus Medical Devices Inc.
  • Table 10.5: Product Mapping: PTW Freiburg GmbH
  • Table 10.6: Product Mapping: Standard Imaging Inc.
  • Table 10.7: Product Mapping: Sun Nuclear Corporation
  • Table 10.8: Product Mapping: The Phantom Laboratory Inc.

List of Figures

  • Figure 1: Number of New Cancer Cases, Global, 2018
  • Figure 2: Impact Analysis of Market Drivers and Challenges
  • Figure 3: Global Radiation Therapy Quality Assurance Phantoms Market (by Region), Market Share, 2018
  • Figure 4: Radiation Therapy Quality Assurance Phantoms Market, Growth Potential, by Country, 2019-2024
  • Figure 5: Global Radiation Therapy QA Phantoms Market (by Region), 2019-2024
  • Figure 6: Market Share Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
  • Figure 2.1: Global Radiation Therapy Quality Assurance Phantoms Market: Segmentation
  • Figure 3.1: Radiation Therapy Quality Assurance Phantoms Market Research Methodology
  • Figure 3.2: Data Triangulation
  • Figure 3.3: Primary Research
  • Figure 3.4: Secondary Research
  • Figure 3.5: Bottom-Up Approach (Segment-wise Analysis)
  • Figure 3.6: Assumptions and Limitations
  • Figure 4.1: Value Analysis of Radiation Therapy Quality Assurance Phantom Market
  • Figure 5.1: Competitive Landscape- Global Radiation Therapy Quality Assurance Phantoms Market
  • Figure 5.2: Market Share Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
  • Figure 5.3: Share of Key Developments and Strategies, January 2013-September 2019
  • Figure 5.4: Collaborations, and Partnerships Share (by Companies), January 2013-September 2019
  • Figure 5.5: Product Launches Share (by Companies), January 2013-September 2019
  • Figure 5.7: Business Expansion Share (by Companies), January 2013-September 2019
  • Figure 6.1: Impact Analysis of Market Drivers and Challenges, 2019-2024
  • Figure 6.2: Number of New Cancer Cases (Global), 2018
  • Figure 7.1: Global Radiation Therapy Quality Assurance Phantoms Market, by Technology, Market Share, 2018
  • Figure 7.2: Global Radiation Therapy Equipment Installations (by Region), 2018
  • Figure 7.3: Linear Accelerators in Radiation QA Phantoms Market (by Value), 2019-2024
  • Figure 7.4: Linear Accelerators in Radiation QA Phantoms Market (by Volume), 2019-2024
  • Figure 7.5: Cobalt-60 in Radiation QA Phantoms Market (by Value), 2019-2024
  • Figure 7.6: Cobalt-60 in Radiation QA Phantoms Market (by Volume), 2019-2024
  • Figure 7.7: High-Dose Radiation in Radiation QA Phantoms Market (by Value), 2019-2024
  • Figure 7.8: High-Dose Radiation in Radiation QA Phantoms Market (by Volume), 2019-2024
  • Figure 7.9: Low-Dose Radiation in Radiation QA Phantoms Market (by Value), 2019-2024
  • Figure 7.10: Low-Dose Radiation in Radiation QA Phantoms Market (by Volume), 2019-2024
  • Figure 8.1: Global Radiation Therapy Quality Assurance Phantoms Market, by Therapy, Market Share, 2018
  • Figure 8.2: Global Radiation Therapy Quality Assurance Phantoms Market, by Therapy, Market Share, 2024
  • Figure 8.3: Photon Beam Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
  • Figure 8.4: Advanced 3D- Conformal Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
  • Figure 8.5: Volumetric Modulated Arc Therapy in Global Radiation QA Phantoms Market, 2019-2024
  • Figure 8.6: Image-Guided Radiation Therapy in Global Radiation QA Phantoms Market, 2019-2024
  • Figure 8.7: Stereotactic Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
  • Figure 8.8: Intraoperative Radiotherapy in Global Radiation QA Phantoms Market, 2019-2024
  • Figure 8.9: Proton Beam Therapy in Global Radiation QA Phantoms Market, 2019-2024
  • Figure 8.10: Neutron Beam Therapy in Global Radiation QA Phantoms Market, 2019-2024
  • Figure 8.11: Brachytherapy in Global Radiation QA Phantoms Market, 2019-2024
  • Figure 9.1: Global Radiation Therapy Quality Assurance Phantoms Market (by Region), Market Share, 2018
  • Figure 9.2: North America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.3: North America- Market Dynamics
  • Figure 9.4: Number of New Cancer Cases in North America, 2018
  • Figure 9.5: North America: Number of Phantoms (by Country), 2018-2024
  • Figure 9.6: Number of New Cancer Cases in U.S., 2018
  • Figure 9.7: U.S.: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.8: Number of New Cancer Cases in Canada, 2018
  • Figure 9.9: Canada: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.10: Europe: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.11: Europe: Radiation Therapy Quality Assurance Phantoms, Market Share (by Country), 2018
  • Figure 9.12: Europe: Market Dynamics
  • Figure 9.13: Number of New Cancer Cases in Europe, 2018
  • Figure 9.14: Europe: Number of Phantoms (by Country), 2018-2024
  • Figure 9.15: Number of New Cancer Cases in Germany, 2018
  • Figure 9.16: Germany: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.17: Number of New Cancer Cases in France, 2018
  • Figure 9.18: France: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.19: Number of New Cancer Cases in Russia, 2018
  • Figure 9.20: Russia: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.21: Number of New Cancer Cases in Italy, 2018
  • Figure 9.22: Italy: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.23: Number of New Cancer Cases in the U.K., 2018
  • Figure 9.24: U.K.: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.25: Number of New Cancer Cases in Spain, 2018
  • Figure 9.26: Spain: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.27: Rest-of-Europe: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.28: Asia-Pacific: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.29: Asia-Pacific: Number of Phantoms (by Country), 2018-2024
  • Figure 9.30: Asia-Pacific: Market Dynamics
  • Figure 9.31: Number of New Cancer Cases in Asia, 2018
  • Figure 9.32: Number of New Cancer Cases in China, 2018
  • Figure 9.33: China: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.34: Number of New Cancer Cases in Japan, 2018
  • Figure 9.35: Japan: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.36: Number of New Cancer Cases in India, 2018
  • Figure 9.37: India: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.38: Number of New Cancer Cases in Australia, 2018
  • Figure 9.39: Australia: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.40: Number of New Cancer Cases in South Korea, 2018
  • Figure 9.41: South Korea: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.42: Rest-of-Asia-Pacific: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.43: Rest-of-the-World: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.44: Rest-of-the-World: Number of Phantoms (by Region), 2018-2024
  • Figure 9.45: Latin America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.46: Latin America: Number of Phantoms (by Country), 2018-2024
  • Figure 9.47: Number of New Cancer Cases in Brazil, 2018
  • Figure 9.48: Brazil: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.49: Number of New Cancer Cases in Mexico, 2018
  • Figure 9.50: Mexico: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.51: Rest-of-Latin-America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.52: Middle East and Africa: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.53: Middle East: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.54: Africa: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
  • Figure 9.55: Number of New Cancer Cases in Saudi Arabia, 2018
  • Figure 9.56: Number of New Cancer Cases in Egypt, 2018
  • Figure 9.57: Number of New Cancer Cases in South Africa, 2018
  • Figure 10.1: Total Number of Companies Profiled
  • Figure 10.2: Modality Supported by Phantoms of CIRS, Inc.
  • Figure 10.3: Computerized Imaging Reference Systems, Inc.: SWOT Analysis
  • Figure 10.4: Modalities Supported by Phantoms of Fluke Biomedical
  • Figure 10.5: Fluke Biomedical: SWOT Analysis
  • Figure 10.6: Modalities Supported by Phantoms of IBA Dosimetry
  • Figure 10.7: IBA Dosimetry: Overall Financials, 2017-2018
  • Figure 10.8: IBA Dosimetry: SWOT Analysis
  • Figure 10.9: Modalities Supported by Phantoms of Modus Medical Devices Inc.
  • Figure 10.10: Modus Medical Devices Inc.: SWOT Analysis
  • Figure 10.11: Modalities Supported by Phantoms of PTW Freiburg GmbH
  • Figure 10.12: PTW Freiburg GmbH: SWOT Analysis
  • Figure 10.13: Modalities Supported by Phantoms of Standard Imaging Inc.
  • Figure 10.14: Standard Imaging Inc.: SWOT Analysis
  • Figure 10.15: Modalities Supported by Phantoms of Sun Nuclear Corporation
  • Figure 10.16: Sun Nuclear Corporation: SWOT Analysis
  • Figure 10.17: Modalities Supported by Phantoms of The Phantom Laboratory Inc.
  • Figure 10.18: The Phantom Laboratory, Inc.: SWOT Analysis